J07AM51 • adult diphtheria + tetanus vaccine • Antiinfectives for systemic use | Bacterial vaccines | Tetanus vaccines
The adult-type diphtheria and tetanus (dT) vaccine is used to prevent diphtheria and tetanus, two serious infectious diseases caused by bacteria. The vaccine contains reduced doses of diphtheria and tetanus toxoids, specifically formulated for adults and adolescents to reduce the risk of adverse reactions.
The vaccine is administered intramuscularly, usually as a booster dose every 10 years, according to vaccination recommendations. It is particularly important for individuals traveling to endemic areas, healthcare workers, and those exposed to contaminated wounds.
Common side effects include pain at the injection site, mild fever, and fatigue. In rare cases, severe allergic reactions may occur.
The dT vaccine is an essential preventive measure for maintaining immunity against diphtheria and tetanus, helping to protect public health and prevent the severe complications associated with these diseases.
Substance: adult diphtheria + tetanus vaccine
Date of last drug list: 01-01-2015
Commercial code: W61037002
Pharmaceutical form: suspension for injection in pre-filled syringe
Quantity: 10
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).